KBio and ZERO’s plant-based partnership

Added on 09 August 2023

Tags

In a groundbreaking move that promises to transform the landscape of biologics production, KBio and ZERO have joined forces to establish the world’s first transportable globally distributed plant-based molecular farming network. KBio, renowned for its expertise in developing biological treatments derived from a plant-based production system, and ZERO, an Italian agtech company specializing in advanced controlled growing environments, are set to combine their strengths to create tailor-made solutions for therapeutic, pandemic preparedness, and bioactive ingredient production.

The strategic alliance between these two innovative companies aims to capitalize on KBio’s groundbreaking N. benthamiana bioreactor technology and ZERO’s automated, modular, and contamination-free vertical plant growing setup. The partnership intends to design and build a diverse portfolio of end-to-end solutions, which can be rapidly deployed worldwide in emergencies or function in large, centralized hubs to provide commercial supply and CDMO (Contract Development and Manufacturing Organization) services to multi-sector customers.

KBio’s status as a world leader in plant-based biologics production stems from its platform’s ability to generate highly pure proteins more efficiently and at a lower cost compared to traditional technologies. Patrick Doyle, the CEO of KBio, emphasized the significance of the collaboration with ZERO, revealing their plans for joint research and development activities in the United States, the UK, and Italy. These initiatives will encompass the production of monoclonal antibodies, vaccines, and various bio-industrial products with diverse applications in the food, nutraceutical, cosmetic, and pharmaceutical sectors.